United States Patent (19) 11) 4,149,021 Wall 45) Apr

Total Page:16

File Type:pdf, Size:1020Kb

United States Patent (19) 11) 4,149,021 Wall 45) Apr United States Patent (19) 11) 4,149,021 Wall 45) Apr. 10, 1979 54 ESTER HYDROGENATION USING COBALT, 2,023,383 12/1935 Schrauth et al. .................... 568/885 ZNC AND COPPER OXDE CATALYST 2,093,159 9/1937 Schmidt ............................... 568/885 2,110,483 3/1938 Guyer .................................. 568/885 (75) Inventor: Robert G. Wall, Pinole, Calif. 2,121,367 6/1938 Schiller ................................ 568/885 (73) Assignee: Chevron Research Company, San 2,285,448 6/1942 Loder ...................so so. 568/864 Francisco, Calif. FOREIGN PATENT DOCUMENTS 21 Appl. No.: 899,759 1146483 4/1963 Fed. Rep. of Germany. 417582 7/1933 United Kingdom. 22 Filed: Apr. 24, 1978 457358 11/1936 United Kingdom. 484995 5/1938 United Kingdom. Related U.S. Application Data Primary Examiner-Joseph E. Evans 60 Division of Ser. No. 790,366, Apr. 25, 1977, Pat. No. Attorney, Agent, or Firm-D. A. Newell; John Stoner, 4,113,662, which is a continuation-in-part of Ser. No. 711,909, Aug. 5, 1976, abandoned, which is a Jr.; A. T. Bertolli continuation-in-part of Ser. No. 578,799, May 19, 1975, 57 ABSTRACT abandoned. A process for hydrogenation of esters to alcohols which (51) Int, Cl’.............................................. CO7C 29/00 comprises contacting the ester with hydrogen and a 52) U.S. C. ..................................... 568/864; 568/885 catalyst comprising cobalt, zinc and copper under cata 58) Field of Search ................................ 568/864, 885 lytic hydrogenation conditions including a temperature between 150' and 450° C. and a pressure of 500-10,000 56) References Cited psig, U.S. PATENT DOCUMENTS 1,949,109 2/1934 Pier et al. ............................. 252/473 10 Claims, No Drawings 4,149,021 1. 2 essentially comprising cobalt in combination with ESTER HYDROGENATIONUSING COBALT, ZINC an activating substance, selected from the class AND COPPER OXDE CATALYST consisting of oxides of metals giving acids with CROSS-REFERENCE TO RELATED oxygen and compounds of alkali, alkaline earth and APPLICATION 5 rare earth metals with metal acids until substantial quantities of alcohols corresponding to the said This application is a division of U.S. application Ser. alkylmonocarboxylic acid radicles are formed.' No. 790,366, filed Apr. 25, 1977, now U.S. Pat. No. According to the disclosure of U.S. Pat. No. 4,113,662, which in turn is a continuation-in-part of U.S. 10 2,093,159, application Ser. No. 711,909, filed Aug. 5, 1976, now "Suitable catalytic substances are for example cop abandoned, which in turn is a continuation-in-part of per, nickel, silver, zinc, cadmium, lead or cobalt or U.S. application Ser. No. 578,799, filed May 19, 1975, mixtures thereof and they may be prepared from now abandoned. their salts, oxides or other compounds prior to or BACKGROUND OF THE INVENTION 15 after an incorporation with activating substances. The present invention relates to the hydrogenation of The activating substances may be chosen from esters to alchols using a solid hydrogenation catalyst. compounds of the metals giving acids with oxygen, The hydrogenation of esters to alcohols is well such as chromium, molybdenum, tungsten, ura known. See, for example, U.S. Pat. No. 1,605,093 dis nium, manganese, vanadium or titanium or mix closing the following ester hydrogenation reaction: 20 tures thereof as well as from compounds of the alkali, alkali earth or rare earth metals.' U.S. Pat. No. 2,109,844 teaches away from the use of cobalt-containing catalysts in converting esters to alco According to U.S. Pat. No. 1,605,093, a copper catalyst hols. At page 5 U.S. Pat. No. 2,109,844 states: is used in the ester hydrogenation. 25 "... if the hydrogenation of a fatty glyceride is to be It is frequently stated that the best method of convert operated for the production of alcohols and esters ing an acid to the corresponding alcohol usually in to the substantial exclusion of hydrocarbons it is volves proceeding through the ester. Esters are nor preferable to select as the catalyst a composition mally obtained from acids in nearly quantitative yields, comprising a member of the group of nonferrous and the esters can be reduced to alcohols, usually with 30 hydrogenating metals such as copper, tin, silver, considerably higher yields than in reducing the corre cadmium, zinc, lead, their oxides and chromites, sponding acid to the alcohol. Esters have been reduced and oxides of manganese and magnesium. Espe using various means such as lithium aluminum hydride, cially good results are obtained with finely divided sodium plus an alcohol, or a solid hydrogenation cata copper oxide, either wholly or partially reduced lyst. These methods are indicated in general by the 35 and preferably supported upon an inert surface equations below: extending material such askieselguhr, or promoted O by such oxide promoters as manganese oxide, zinc I R-C + 4H) oxide, magnesium oxide, or chromium oxide. The (LiAlH4) above mentioned mild-acting catalysts may be OCH3 termed the alcohol-forming catalysts to distinguish R-CH-OH + CH3-OH, them from the more energetic ferrous metal (as Li or Al alkoxides) groups. Elementary nickel, cobalt, and iron when O suitably supported on kieselguhr may be used to I effect the reduction of fatty glycerides with hydro R-C -- 4(H) 45 (Na + C2H5OH) gen, but in these cases the product contains besides OC2H5 alcohols and waxes a preponderance of hydrocar R-CH2-OH + C2H5-OH bons, and this disadvantage in most cases will O prove so serious as to preclude the use of these I catalysts unless the hydrocarbons themselves are R- + 2H2 50 the desired end products.” OC2H5 Other patents which disclose catalysts for hydrogena nickel G tion of esters and carboxylic acids include U.S. Pat. or Nos. 2,110,843; 2,118,007; 2,121,367; 2,782,243; CuCr2O4 is 3,173,959 (copper-zinc chromite catalyst for ester re A, high pressure duction); 3,267,157 (activated copper chromite catalyst R-CH2-OH + C2Hs-OH for acid and ester hydrogenation). Besides copper chromite as an ester hydrogenation U.S. Pat. No. 2,285,448 discloses hydrogenation of catalyst, as indicated in the last equation above, other glycolic acid and its esters to obtain ethylene glycol. hydrogenation catalysts, such as the copper chromite/- 60 According to U.S. Pat. No. 2,285,448, a copper-mag barium catalyst in U.S. Pat. No. 2,091,800 to Homer nesium catalyst is preferred. At column 2, line 46 of Adkins et al, have been disclosed. U.S. Pat. No. 2,285,448 it is stated that: U.S. Pat. No. 2,093,159 discloses a "In place of magnesium oxide, other metal oxides "process for the catalytic hydrogenation of esters of which promote the activity of the copper oxide aliphatic alkylmonocarboxylic acids, which com 65 may be employed such, for example, as an oxide of prises passing the said esters together with hydro nickel, iron, cobalt, manganese, chromium, cal gen while heating to a temperature of the range cium, barium, strontium, potassium, caesium, zinc, from 200 to 400° C. over a hydrogenating catalyst cadmium and silver, or mixtures thereof.” 4,149,021 3 4 which may be branched chain, and preferably is satu SUMMARY OF THE INVENTION rated with hydrogen. According to the present invention a process is pro The term "carboxylic acid esters' is used herein in vided for hydrogenation of carboxylic acid esters to the sense of esters composed of carbon, hydrogen, and alcohols, which process comprises contacting the ester 5 oxygen and preferably not containing any halogen, with hydrogen gas and a catalyst comprising cobalt, sulfur or nitrogen-that is, at least no halogen, sulfur, or zinc and copper under catalytic hydrogenation condi nitrogen or the like in an active form or degradable tions including a temperature between 150' and 450° C. form such that the ester hydrogenation reaction is sub and pressures of 500 to 10,000 psi. This may be either a stantially prevented. liquid or vapor phase process, preferably liquid phase. 10 The most preferred feeds for the process of the pres Among other factors, the present invention is based ent invention are ethylene glycol glycolate, diethylene on my finding that the cobalt-zinc-copper catalyst is a glycol glycolate, and polyglycolides (typically the highly effective ester hydrogenation catalyst in terms of polyglycolide feeds are in the form of an alkyl glycolate activity, selectivity, and stability. The high stability of obtained from the polyglycolide and solvent alcohol). the catalyst is particularly surprising since catalytically The ethylene glycol glycolate can be obtained from active cupric oxide would be expected to be reduced to glycolic acid by reaction of ethylene glycol with gly inactive copper metal under the hydrogenation condi colic acid or its oligomers under usual esterification tions. In Organic Reactions, vol. VIII (1954), published conditions. Likewise, the diethylene glycol glycolate can be obtained by reaction of glycolic acid or its oligo by John Wiley & Sons, New York, on page 8 concern mers with diethylene glycol. Both the monoglycolates ing copper chromite Adkins states: and the bisglycolates of these glycol solvents, i.e., ethyl "The catalyst is inactivated if, through excessive ene glycol and diethylene glycol, can be hydrogenated temperatures in the preparation or use of the cata in the present process. lyst, the cupric oxide reacts with cupric chromite Polyglycolide can be obtained by dehydrating gly to give cuprous chromite, Cu2Cr2O4, and oxygen. 25 colic acid, for example by heating glycolic acid under However, the most frequent cause of inactivation vacuum and removing water. Preferably the process of of the catalyst is the reduction of the cupric oxide the present invention is carried out in the presence of an to copper.
Recommended publications
  • Bioplastics: Biobased Plastics As Renewable And/Or Biodegradable Alternatives to Petroplastics
    BIOPLASTICS: BIOBASED PLASTICS AS RENEWABLE AND/OR BIODEGRADABLE ALTERNATIVES TO PETROPLASTICS 1. Introduction ‘‘Plastics’’ were introduced approximately 100 years ago, and today are one of the most used and most versatile materials. Yet society is fundamentally ambivalent toward plastics, due to their environmental implications, so interest in bioplastics has sparked. According to the petrochemical market information provider ICIS, ‘‘The emergence of bio-feedstocks and bio-based commodity polymers production, in tandem with increasing oil prices, rising consumer consciousness and improving economics, has ushered in a new and exciting era of bioplastics commercialization. However, factors such as economic viability, product quality and scale of operation will still play important roles in determining a bioplastic’s place on the commer- cialization spectrum’’ (1). The annual production of synthetic polymers (‘‘plastics’’), most of which are derived from petrochemicals, exceeds 300 million tons (2), having replaced traditional materials such as wood, stone, horn, ceramics, glass, leather, steel, concrete, and others. They are multitalented, durable, cost effective, easy to process, impervious to water, and have enabled applications that were not possible before the materials’ availability. Plastics, which consist of polymers and additives, are defined by their set of properties such as hardness, density, thermal insulation, electrical isolation, and primarily their resistance to heat, organic solvents, oxidation, and microorgan- isms. There are hundreds of different plastics; even within one type, various grades exist (eg, low viscosity polypropylene (PP) for injection molding, high viscosity PP for extrusion, and mineral-filled grades). Applications for polymeric materials are virtually endless; they are used as construction and building material, for packaging, appliances, toys, and furniture, in cars, as colloids in paints, and in medical applications, to name but a few.
    [Show full text]
  • The Recent Developments in Biobased Polymers Toward
    polymers Review The Recent Developments in Biobased Polymers toward General and Engineering Applications: Polymers that Are Upgraded from Biodegradable Polymers, Analogous to Petroleum-Derived Polymers, and Newly Developed Hajime Nakajima, Peter Dijkstra and Katja Loos * ID Macromolecular Chemistry and New Polymeric Materials, Zernike Institute for Advanced Materials, University of Groningen, Nijenborgh 4, 9747 AG Groningen, The Netherlands; [email protected] (H.N.); [email protected] (P.D.) * Correspondence: [email protected]; Tel.: +31-50-363-6867 Received: 31 August 2017; Accepted: 18 September 2017; Published: 18 October 2017 Abstract: The main motivation for development of biobased polymers was their biodegradability, which is becoming important due to strong public concern about waste. Reflecting recent changes in the polymer industry, the sustainability of biobased polymers allows them to be used for general and engineering applications. This expansion is driven by the remarkable progress in the processes for refining biomass feedstocks to produce biobased building blocks that allow biobased polymers to have more versatile and adaptable polymer chemical structures and to achieve target properties and functionalities. In this review, biobased polymers are categorized as those that are: (1) upgrades from biodegradable polylactides (PLA), polyhydroxyalkanoates (PHAs), and others; (2) analogous to petroleum-derived polymers such as bio-poly(ethylene terephthalate) (bio-PET); and (3) new biobased polymers such as poly(ethylene 2,5-furandicarboxylate)
    [Show full text]
  • 35Cl NQR Study of Cation Polarizability in Metal Salts of Monochloro Acetic Acid
    Vol. 113 (2008) ACTA PHYSICA POLONICA A No. 6 35Cl NQR Study of Cation Polarizability in Metal Salts of Monochloro Acetic Acid D. Ramanandaa;¤, L. Ramub, K.P. Rameshc, R. Chandramanib and J. Uchild aDepartment of Materials Science, Mangalore University Karnataka 574199, India bDepartment of Physics, Bangalore University Bangalore 560 006, India cDepartment of Physics, Indian Institute of Science Bangalore 560 012, India dDepartment of PG studies in Physics, SBMJ College Bangalore, India (Received November 2, 2007; in ¯nal form March 3, 2008) Various metal salts (Na, K, Rb, and NH4) of monochloro acetic acid were prepared and the 35Cl nuclear quadrupole resonance frequencies were measured at room temperature. A comparative study of nuclear quadrupole resonance frequencies of monochloro acetic acid and its metal salts is carried out. The frequency shifts obtained in the respective metal chloroacetates are used to estimate the changes in the ionicity of C{Cl bond. Further, the changes in the ionicity of C{Cl bond were used to estimate the percentage of intra-molecular charge transfer between respective cation{anion of the metal salts of chloro acetic acid. The nuclear quadrupole resonance frequency is found to decrease with increasing ionicity of the alkali metal ion. PACS numbers: 76.60.Gv 1. Introduction The aim of the present work is to ¯nd a correlation between the 35Cl nuclear quadrupole resonance (NQR) frequency and the cation polarizability. Various crys- ¡ + talline metal salts of monochloro acetic acid of general formula, CH2ClCOO M (M = Na, K, Rb, NH4) are obtained by the replacement of hydrogen atom in the chloro acetic acid by metal ions such as sodium/potassium/rubidium and ammo- nium.
    [Show full text]
  • Rapid Continuous 3D Printing of Customizable Peripheral Nerve Guidance
    Materials Today d Volume xxx, Number xx d xxxx 2017 RESEARCH Rapid continuous 3D printing of customizable peripheral nerve guidance conduits RESEARCH: Original Research Wei Zhu 1,†, Kathryn R. Tringale 2,3,†, Sarah A. Woller 4, Shangting You 1, Susie Johnson 2,3, Haixu Shen 1, Jacob Schimelman 1, Michael Whitney 2,3, Joanne Steinauer 4, Weizhe Xu 5, Tony L. Yaksh 4, Quyen T. Nguyen 2,3,⇑, Shaochen Chen 1,5,⇑ 1 Department of NanoEngineering, University of California San Diego, La Jolla, CA 92093, United States 2 Department of Surgery, University of California San Diego, La Jolla, CA 92093, United States 3 Department of Pharmacology, University of California San Diego, La Jolla, CA 92093, United States 4 Department of Anesthesiology, University of California San Diego, La Jolla, CA 92093, United States 5 Department of Bioengineering, University of California San Diego, La Jolla, CA 92093, United States Engineered nerve guidance conduits (NGCs) have been demonstrated for repairing peripheral nerve injuries. However, there remains a need for an advanced biofabrication system to build NGCs with complex architectures, tunable material properties, and customizable geometrical control. Here, a rapid continuous 3D-printing platform was developed to print customizable NGCs with unprecedented resolution, speed, flexibility, and scalability. A variety of NGC designs varying in complexity and size were created including a life-size biomimetic branched human facial NGC. In vivo implantation of NGCs with microchannels into complete sciatic nerve transections of mouse models demonstrated the effective directional guidance of regenerating sciatic nerves via branching into the microchannels and extending toward the distal end of the injury site.
    [Show full text]
  • Scaffolds with Tunable Properties Constituted by Electrospun Nanofibers of Polyglycolide and Poly(Ε-Caprolactone)
    SCAFFOLDS WITH TUNABLE PROPERTIES CONSTITUTED BY ELECTROSPUN NANOFIBERS OF POLYGLYCOLIDE AND POLY( ε-CAPROLACTONE) Ina Keridou1, Lourdes Franco1,2, Pau Turon3, Luis J. del Valle1,2 1,2* Jordi Puiggalí 1Departament d'Enginyeria Química, Universitat Politècnica de Catalunya, Escola d’Enginyeria de Barcelona Est-EEBE, c/Eduard Maristany 10-14, Barcelona 08019, SPAIN 2Center for Research in Nano-Engineering, Universitat Politècnica de Catalunya, Campus Sud, Edifici C’, c/Pasqual i Vila s/n, Barcelona E-08028, SPAIN 3B. Braun Surgical, S.A. Carretera de Terrasa 121, 08191 Rubí (Barcelona), SPAIN Correspondence to: J. Puiggalí (E-mail: [email protected]) 1 ABSTRACT Electrospun scaffolds constituted by different mixtures of two biodegradable polyesters have been prepared. Specifically, materials with well differentiated properties can be derived from the blending of hydrophilic polyglycolide (PGA) and hydrophobic poly(ε- caprolactone) (PCL), which are also two of the most applied polymers for biomedical uses. Electrospinning conditions have been selected in order to get homogeneous and continuous fibers with diameters in the nano/micrometric range. These conditions were also applied to load the different scaffolds with curcumin (CUR) and polyhexamethylene biguanide (PHMB) as hydrophobic and hydrophilic bactericide compounds, respectively. Physicochemical characterization of both unloaded and loaded scaffolds was performed and involved FTIR and 1H NMR spectroscopies, morphological observations by scanning electron microscopy, study of thermal properties through calorimetry and thermogravimetric analysis and evaluation of surface characteristics through contact angle measurements. Release behavior of the loaded scaffolds was evaluated in two different media. Results pointed out a well differentiated behavior where the delivery of CUR and even PHMB were highly dependent on the PGA/PCL ratio, the capability of the medium to swell the polymer matrix and the diffusion of the selected solvent into the electrospun fibers.
    [Show full text]
  • Synthesis and Degradation Behavior of Miktoarm Poly(&Epsiv;-Caprolactone)2-B-Poly(L-Lactone)2 Microspheres
    Polymer Journal (2013) 45, 420–426 & 2013 The Society of Polymer Science, Japan (SPSJ) All rights reserved 0032-3896/13 www.nature.com/pj ORIGINAL ARTICLE Synthesis and degradation behavior of miktoarm poly(e-caprolactone)2-b-poly(L-lactone)2 microspheres Xi Zhang, Yan Xiao and Meidong Lang Poly(e-caprolactone)2-b-poly(L-lactide)2 miktoarm block copolymers were successfully synthesized via ring-opening polymerization using pentaerythritol as the initiator and a protection–deprotection procedure. 1H nuclear magnetic resonance (1H NMR) and size exclusion chromatography (SEC) were employed to characterize the miktoarm structure, molecular weight and molecular weight distribution. The microspheres of poly(e-caprolactone)2-b-poly(L-lactide)2 ((PCL)2-b-(PLLA)2) were produced by an oil-in-water emulsion solvent extraction/evaporation method and studied with scanning electron microscopy (SEM). The hydrolytic degradation of microspheres with different architectures and compositions was performed at 37 1C in a phosphate-buffered saline solution (pH ¼ 7.4). The weight loss of the microspheres was strongly affected by the molecular architecture, chain length and composition. The compositional, or molar ratio, changes were monitored during the degradation using 1H NMR, SEC, differential scanning calorimetry and SEM, all of which suggested that the degradation proceeded from the surface to the interior and could be described using a combined degradation model with surface erosion and bulk degradation. Polymer Journal (2013) 45, 420–426; doi:10.1038/pj.2012.166; published online 10 October 2012 Keywords: microsphere; miktoarm; PCL; PLLA; pentaerythritol INTRODUCTION Therefore, the ‘core-first’ method was applied in our work to ensure Biodegradable aliphatic polyesters, such as poly(e-caprolactone) the desired miktoarm structure.
    [Show full text]
  • Confirmation of the Sterility of Medical Devices and Changes in the Characteristics of Polymers Upon Sterilization
    Biocontrol Science, 2001, Vol.6, No.2, 63-68 Minireview Confirmation of the Sterility of Medical Devices and Changes in the Characteristics of Polymers upon Sterilization HIDEHARU SHINTANI National Institute of Health Sciences, 1-18-1, Kamiyoga, Setagaya, Tokyo 151-0041, Japan Received 15 November 2000/Accepted 20 November 2000 Key words : Sterility/Sterilization/Medical Devices. STERILITY be sterile complies with the requirements set forth in the individual monograph with respect to the test for Medical devices may be sold and used in two differ- sterility. In view of the possibility that positive results ent conditions in terms of their bioburden (that is, the may be due to faulty aseptic techniques or environ- number of viable microorganisms present on the de- mental contamination during testing, provisions are in- vice) : sterile or nonsterile. If they are intended to be cluded under the interpretation of sterility test results used in the sterile condition, the actual act of steriliza- for two stages of testing. tion may be either performed by the manufacturer or Alternative procedures may be employed to demon- by the user (though the latter is commonly the case strate that an article is sterile, provided the results ob- only for reusable devices and instruments, such as tained are equivalent or greater reliability. When a surgical instruments at a health care facility). If the difference appears or dispute occurs, evidence of mi- manufacturer has sterilized the instruments, then this crobial contamination must be confirmed by the vali- is specified in the Device Master File (and in product dated procedure. The result so obtained is conclusive related literature), along with the means for having of the failure of the article to meet the requirements of achieved a suitable degree of sterilization and specifi- the test.
    [Show full text]
  • Biodegradable Polymers: Production...”, Technologica Acta, Vol
    CORE Metadata, citation and similar papers at core.ac.uk A. Cipurković, E. Horozić, N. Đonlagić, S. Marić, M. Saletović, Z. Ademović, “Biodegradable polymers: production...”, Technologica Acta, vol. 11, no. 1, pp. 25–35, 2018. 25 BIODEGRADABLE POLYMERS: PRODUCTION, PROPERTIES AND APPLICATION IN MEDICINE SCIENTIFIC REVIEW PAPER Amira Cipurković1, Emir Horozić2, Nusreta Đonlagić1, Snježana Marić1, Mirzeta Saletović1, Zahida Ademović2 RECEIVED ACCEPTED 1Faculty of Natural Science and Mathematics, University of Tuzla, Bosnia and Herzegovina 2018-01-22 2018-05-18 2Faculty of Technology, University of Tuzla, Bosnia and Herzegovina * [email protected] ABSTRACT: Biodegradable polymers (biopolymers) represent materials of new generation with application in different areas of human activity. Their production has recently reached a commercial level. They can be divided according to the origin (natural and synthetic), according to the chemical composition, methods of obtaining, ap- plication etc. The use of biopolymers in medicine depends on their biocompatibility, mechanical resistance, and sorptive characteristics. Today, they are the most commonly used as implants in vascular and orthopedic surgery, for the production of materials such as catheters, products for gynaecology and haemodialysis, tooth reconstruc- tion, etc. In pharmacy, they are used as a medicine matrix-carrier to allow controlled release of drug within the body. Within this review paper, the properties and methods of production of certain biopolymers such as polygly- colic acid (PGA), polylactide acid (PLA), poly-ε-coprolactone (PCL) and polybutylene succinate (PBS) will be de- scribed in detail, as well as their application in medicine and pharmacy. KEYWORDS: polyglycolic acid (PGA), polylactide acid (PLA), poly-ε-coprolactone (PCL), polybutylene succi- nate (PBS) INTRODUCTION amide, or ether chemical bonds.
    [Show full text]
  • Biodegradable Polyesters: Synthesis, Properties, Applications Chi Zhang
    1 1 Biodegradable Polyesters: Synthesis, Properties, Applications Chi Zhang 1.1 Historical Overview on the Origin of Polymer Science and Synthesis of Polyamides and Polyesters There are some persons who stand out prominently in any review of the history of polyesters. As early as in 1911, Meyer [1] found that the saponification of polyesters of polyacids and polyalcohols and the hydrolysis of a glycerol ester proceeds in acid and alkaline solution, and, the hydrolysis can only be detected under certain conditions with heterogeneous saponification. However, he did not mention the molecular weights of the polyesters used. Hermann Staudinger (1881–1965) is recognized as the father of polymer chemistry because of his great contributions to polymer science (Figure 1.1). In 1920, Staudinger reported [3] that polymerization processes in the wider sense are all processes in which two or more molecules combined to a result in a product of the same composition but with higher molecular weight. These high-molecular-weight compounds are produced by two basic polymerization processes: the first was called condensation polymerization(nowadays, termed step-growth polymerization) in which polymers are formed by stepwise reactions between functional groups of monomers, usually containing heteroatoms such as nitrogen or oxygen; and the second called chain-growth polymerization (or addition polymerization), which involves double or triple carbon–carbon bonds breaking and the linking together of the other molecules. In reactions, these unsaturated monomers are able to form repeating units where the main-chain backbone usually contains only carbon atoms. In his paper entitled “Polymeriza- tion” [3], Staudinger presented several reactions that form high-molecular-weight molecules by linking together a large number of small molecules.
    [Show full text]
  • P Oly-D,L-Lactide–Co-Poly(Ethylene Glycol)
    中国科技论文在线 http://www.paper.edu.cn Journal of Controlled Release 86 (2003) 195–205 www.elsevier.com/locate/jconrel Review P oly-D,L-lactide–co-poly(ethylene glycol) microspheres as potential vaccine delivery systems Shaobing Zhoua,* , Xueyan Liao b , Xiaohong Li a , Xianmo Deng a , Heming Li b aChengdu Institute of Organic Chemistry, Chinese Academy of Sciences, P.O. Box 415, Chengdu 610041, PR China bNational Institute of the Control for Pharmaceutical and Biological Products, Beijing, 100050, PR China Received 1 September 2002; accepted 8 November 2002 Abstract Adjuvants aimed at increasing the immunogenicity of recombinant antigens remain a focus in vaccine development. Worldwide, there is currently considerable care for the development of biodegradable microspheres as controlled release of vaccines, since the major disadvantage of several currently available vaccines is the need for repeated administration. Microspheres prepared from the biodegradable and biocompatible polymers, the polylactide (PLA) or polylactide–co- glycolide (PLGA), have been shown to be effective adjuvants for a number of antigens. This review mainly focuses on polylactide–co-poly(ethylene glycol) (PELA) microspheres adjuvant as vaccine delivery systems by summarizing our and other research groups’ investigation on properties of the microspheres formulation encapsulating several kinds of antigens. The results indicate that compared with the commonly used PLA and PLGA, PELA showed several potentials in vaccine delivery systems, which may be due to the block copolymer have its capability to provide a biomaterial having a broad range of amphiphilic structure. PELA microspheres can control the rate of release of entrapped antigens and therefore, offer potential for the development of single-dose vaccines.
    [Show full text]
  • Polymeric Medical Sutures: an Exploration of Polymers and Green Chemistry Instructor Notes
    Polymeric Medical Sutures: An Exploration of Polymers and Green Chemistry Instructor Notes Part I: Drawing Threads Using Poly(-caprolactone) General Notes: ● Part I should take 45 minutes, depending on the depth of the introduction to the lab. The introduction takes about 15 minutes, the melting of the poly(ε-caprolactone) takes about 15 minutes, and the drawing of the threads takes about 15 minutes. ● Consider including a demonstration during the introduction that mimics the entanglement of polymers of varying molecular mass with strings cut to varying lengths. ○ Prep: Have 6-10 small (3-5 inches) pieces of yarn cut up and 6-10 large (24 inches) pieces of yarn cut up. Arrange all the small pieces in a pile and the large pieces in a separate pile. ○ Demonstration: Attempt to pull a piece of yarn out of each of the piles to show how larger polymers can entangle easier than small polymers. Discuss what might happen when 14K, 45K, and 80K polymers are pulled into a suture and how their entanglement will affect the quality of the suture. ● Part I includes showing students an example of real sutures. There are many possible options for sutures, including those suggested below. A minimum of one type is necessary for the purpose of this experiment. ● Plastic bags can be used for ease of collecting and storing the sutures. Have students label the plastic bags using labeling tape and a permanent marker so the bags can be reused each year. ● The 80K poly(ε-caprolactone) can be drawn into lengthy sutures. You may consider having a drawing contest to see which students can draw the longest sutures.
    [Show full text]
  • Progress in Polymer Science
    QUT Digital Repository: http://eprints.qut.edu.au/ This is the author version published as: This is the accepted version of this article. To be published as : This is the author version published as: Woodruff, Maria A. and Hutmacher, Dietmar W. (2010) The return of a forgotten polymer : Polycaprolactone in the 21st century. Progress in Polymer Science. Copyright 2010 Elsevier The return of a forgotten polymer – Polycaprolactone in the 21st century Maria Ann Woodruff and Dietmar Werner Hutmacher Institute of Health and Biomedical Innovation, Queensland University of Technology, 60 Musk Avenue, Kelvin Grove, QLD, Australia 4059. Abstract During the resorbable-polymer-boom of the 1970s and 1980s, polycaprolactone (PCL) was used in the biomaterials field and a number of drug-delivery devices. Its popularity was soon superseded by faster resorbable polymers which had fewer perceived disadvantages associated with long term degradation (up to 3-4 years) and intracellular resorption pathways; consequently, PCL was almost forgotten for most of two decades. Recently, a resurgence of interest has propelled PCL back into the biomaterials-arena. The superior rheological and viscoelastic properties over many of its aliphatic polyester counterparts renders PCL easy to manufacture and manipulate into a large range of implants and devices. Coupled with relatively inexpensive production routes and FDA approval, this provides a promising platform for the production of longer-term degradable implants which may be manipulated physically, chemically and biologically to possess tailorable degradation kinetics to suit a specific anatomical site. This review will discuss the application of PCL as a biomaterial over the last two decades focusing on the advantages which have propagated its return into the spotlight with a particular focus on medical devices, drug delivery and tissue engineering.
    [Show full text]